Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Bladder Cancer

Free Subscription Articles published in Oncogene Retrieve available abstracts of 31 articles: HTML format

Single Articles

September 2026
1. QIAN L, Liu B, Zhang R, Zhang W, et al
   Epithelial tumor suppressor deletion promotes neuroendocrine differentiation in bladder cancer and reveals homoharringtonine as a candidate vulnerability.
   Oncogene. 2026 Sep 16. doi: 10.1038/s41388-026-03975.
   PubMed     Abstract available
   
   
   August 2026
2. WEI H, Bai R, Liu J, Lyu L, et al
   POC1A promotes the proliferation, metastasis and stemness of bladder cancer by stabilizing BMI1 via USP7.
   Oncogene. 2026 Aug 31. doi: 10.1038/s41388-026-03973.
   PubMed     Abstract available
   
   
   
3. ZHAO Y, Xing Z, Wang M, Fu L, et al
   DHCR24(+) tumor epithelial cells drive cisplatin resistance in bladder cancer by enhancing cholesterol metabolism to activate lipid raft-associated MAPK signaling.
   Oncogene. 2026 Aug 29. doi: 10.1038/s41388-026-03967.
   PubMed     Abstract available
   
   
   July 2026
4. GAO Y, Chen C, Sun R, Yao Y, et al
   LncRMRP drives bladder cancer invasion via a lactylation-driven positive feedback circuit.
   Oncogene. 2026 Jul 30. doi: 10.1038/s41388-026-03927.
   PubMed     Abstract available
   
   
   
5. ZHAN Y, Zhu C, Li Y, Wen C, et al
   Transcription factor EN1 governs a lipogenic USP18-ACLY axis to drive bladder cancer malignancy.
   Oncogene. 2026 Jul 28. doi: 10.1038/s41388-026-03910.
   PubMed     Abstract available
   
   
   
6. XIONG R, Wang M, Du J, Chai B, et al
   USP15-mediated deubiquitination of FIS1 impairs mitochondrial function and sensitizes bladder cancer cells to radiotherapy.
   Oncogene. 2026 Jul 27. doi: 10.1038/s41388-026-03918.
   PubMed     Abstract available
   
   
   
7. CHENG Y, Chen Y, Wang J, Shu Z, et al
   DTX3 promotes anti-tumor immunity by inducing PD-L1 ubiquitination and is suppressed by p65/miR-222 in bladder cancer.
   Oncogene. 2026 Jul 24. doi: 10.1038/s41388-026-03915.
   PubMed     Abstract available
   
   
   
8. SUN L, Yao Y, Gong S, Chen Z, et al
   YME1L1 degradation by TRIM21 inhibits bladder cancer proliferation, metastasis, and mitochondrial function.
   Oncogene. 2026 Jul 20. doi: 10.1038/s41388-026-03903.
   PubMed     Abstract available
   
   
   April 2026
9. XIAO M, Ma Y, Zhang G, Chen G, et al
   SRSF10 promotes cisplatin resistance in bladder cancer via BIN1 Exon 12 retention and ANXA1 activation.
   Oncogene. 2026 Apr 6. doi: 10.1038/s41388-026-03735.
   PubMed     Abstract available
   
   
   March 2026
10. HU H, Zhan X, Xiong Y, Yuan R, et al
    Non-classic deubiquitinase USP13 inhibits bladder cancer metastasis through destabilizing cytoplasmic KDM3A.
    Oncogene. 2026 Mar 24. doi: 10.1038/s41388-026-03730.
    PubMed     Abstract available
    
    
    February 2026
11. WANG J, Wang J, Meng L, Wang X, et al
    Interstitial cystitis-related gene CCDC8 accelerates tumorigenesis by participating in CUL7-mediated degradation of P53 in bladder cancer.
    Oncogene. 2026 Feb 5. doi: 10.1038/s41388-026-03688.
    PubMed     Abstract available
    
    
    November 2025
12. DONG Y, Jiang X, Yang X, Zhang J, et al
    SQLE drives bladder cancer progression by boosting mitochondrial oxidative phosphorylation.
    Oncogene. 2025 Nov 18. doi: 10.1038/s41388-025-03626.
    PubMed     Abstract available
    
    
    September 2025
13. XIE J, Zhang H, Wang K, Ni J, et al
    Correction: M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.
    Oncogene. 2025 Sep 17. doi: 10.1038/s41388-025-03575.
    PubMed    
    
    
    
14. WANG Y, Jerome NA, Kelleher AJ, Henderson ML, et al
    TRIM29 promotes bladder cancer invasion by regulating the intermediate filament network and focal adhesion.
    Oncogene. 2025 Sep 4. doi: 10.1038/s41388-025-03557.
    PubMed     Abstract available
    
    
    July 2025
15. HU H, Zhan X, Xiong Y, Yuan R, et al
    Retraction Note: Non-classic deubiquitinase USP13 inhibits bladder cancer metastasis through destabilizing cytoplasmic KDM3A.
    Oncogene. 2025 Jul 30. doi: 10.1038/s41388-025-03520.
    PubMed    
    
    
    
16. LUO Y, Zeng Y, Liu Y, Liu S, et al
    ACSL5 regulated acetyl-CoA to promote bladder cancer cellular senescence via 53BP1 acetylation.
    Oncogene. 2025 Jul 1. doi: 10.1038/s41388-025-03474.
    PubMed     Abstract available
    
    
    June 2025
17. ZHANG B, Dong G, Guo X, Li H, et al
    SFXN1 promotes bladder cancer metastasis by restraining PINK1-dependent mitophagy.
    Oncogene. 2025 Jun 4. doi: 10.1038/s41388-025-03460.
    PubMed     Abstract available
    
    
    May 2025
18. WEI X, Wang B, Yang Y, Fang Z, et al
    Crosstalk between SUMOylation and ubiquitination controls the stability of transcription factor zinc finger protein 24: a novel antitumor mechanism in bladder cancer.
    Oncogene. 2025 May 28. doi: 10.1038/s41388-025-03450.
    PubMed     Abstract available
    
    
    
19. HAMADA A, Kita Y, Sakatani T, Nakamura K, et al
    PTEN loss drives p53 LOH and immune evasion in a novel urothelial organoid model harboring p53 missense mutations.
    Oncogene. 2025;44:1336-1349.
    PubMed     Abstract available
    
    
    April 2025
20. HU H, Zhan X, Xiong Y, Yuan R, et al
    Non-classic deubiquitinase USP13 inhibits bladder cancer metastasis through destabilizing cytoplasmic KDM3A.
    Oncogene. 2025 Apr 19. doi: 10.1038/s41388-025-03410.
    PubMed     Abstract available
    
    
    
21. WU CH, Yuen KL, Molony RD, Silvers CR, et al
    Protein disulfide isomerase-enriched extracellular vesicles from bladder cancer cells support tumor survival and malignant transformation in the bladder.
    Oncogene. 2025 Apr 11. doi: 10.1038/s41388-025-03380.
    PubMed     Abstract available
    
    
    August 2024
22. DU K, Luo Y, Zhang L, Zeng Y, et al
    m(6)A modification of lipoyltransferase 1 inhibits bladder cancer progression by activating cuproptosis.
    Oncogene. 2024 Aug 28. doi: 10.1038/s41388-024-03139.
    PubMed     Abstract available
    
    
    
23. WANG X, Guo T, Niu L, Zheng B, et al
    Engineered targeting OIP5 sensitizes bladder cancer to chemotherapy resistance via TRIP12-PPP1CB-YBX1 axis.
    Oncogene. 2024 Aug 18. doi: 10.1038/s41388-024-03136.
    PubMed     Abstract available
    
    
    January 2024
24. CAI H, Ke ZB, Chen JY, Li XD, et al
    Ubiquitin-specific protease 5 promotes bladder cancer progression through stabilizing Twist1.
    Oncogene. 2024 Jan 13. doi: 10.1038/s41388-023-02936.
    PubMed     Abstract available
    
    
    
25. ZHOU F, Deng Z, Shen D, Lu M, et al
    DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing E2F1 via USP11.
    Oncogene. 2024 Jan 5. doi: 10.1038/s41388-023-02932.
    PubMed     Abstract available
    
    
    December 2023
26. YU J, Li M, Ju L, Zhou F, et al
    TRAIP suppresses bladder cancer progression by catalyzing K48-linked polyubiquitination of MYC.
    Oncogene. 2023 Dec 20. doi: 10.1038/s41388-023-02922.
    PubMed     Abstract available
    
    
    November 2023
27. RAMAL M, Corral S, Kalisz M, Lapi E, et al
    The urothelial gene regulatory network: understanding biology to improve bladder cancer management.
    Oncogene. 2023 Nov 23. doi: 10.1038/s41388-023-02876.
    PubMed     Abstract available
    
    
    August 2023
28. XIE J, Zhang H, Wang K, Ni J, et al
    M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.
    Oncogene. 2023 Aug 23. doi: 10.1038/s41388-023-02814.
    PubMed     Abstract available
    
    
    May 2023
29. JIA Y, Ding X, Zhou L, Zhang L, et al
    Retraction Note: Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1.
    Oncogene. 2023 May 30. doi: 10.1038/s41388-023-02726.
    PubMed    
    
    
    March 2023
30. NEYRET-KAHN H, Fontugne J, Meng XY, Groeneveld CS, et al
    Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks.
    Oncogene. 2023 Mar 22. doi: 10.1038/s41388-023-02662.
    PubMed     Abstract available
    
    
    
31. SUN J, Zhang H, Wei W, Xiao X, et al
    Regulation of CD8(+) T cells infiltration and immunotherapy by circMGA/HNRNPL complex in bladder cancer.
    Oncogene. 2023 Mar 3. doi: 10.1038/s41388-023-02637.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum